Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    15121408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
Condition: Graft Versus Host Disease
Interventions: Biological: Mesenchymal Stem Cells;   Biological: placebo
2 Recruiting MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD
Condition: Acute Graft-versus-host Disease
Interventions: Drug: CD25 monoclonal antibody;   Drug: calcineurin inhibitors;   Biological: MSCs
3 Enrolling by invitation Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.
Condition: Severe Aplastic Anemia
Intervention: Biological: mesenchymal stem cells
4 Completed Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
Condition: Graft vs Host Disease
Interventions: Drug: Prochymal - 2 million cells;   Drug: Prochymal - 8 million cells

Indicates status has not been verified in more than two years